IDH1 and giant cell tumor: According to the primary diagnosis in this cohort, we also detected H3F3A in giant cell tumor of bone and malignant giant cell tumor of bone, IDH1/IDH2 mutations in chondrosarcoma, and NCOA2 fusion in mesenchymal chondrosarcoma.